Jim McDermott: Treating the Whole Patient for Diabetes

There are many factors and comorbidities to consider when treating diabetes. Finding the balance of treatment through medications can determine the quality of life of patients as they navigate through the condition.

Speaking at the annual meeting of the American Diabetes Association in New Orleans, Jim McDermott, of AstraZeneca discussed some of the challenges of treating patients with the condition and what can be done to help them in the future.